Public data · refreshed daily
The people who move stocks leave a paper trail - in SEC filings, fund flows and FDA dockets. ClawTerminal reads all of it. Here's a live slice of what the terminal sees today.
8-K material events, ranked by the move they triggered - earnings, catalysts, executive exits. Reverse-split and ETF-split artifacts filtered out.
13D filings flag investors crossing 5% with intent to influence - the classic activist / strategic-control footprint.
Cluster buys - three or more distinct insiders purchasing the same name in one week. PIPE and issuance rows are excluded, and so are newly-listed names and clusters where every insider paid one identical price on one day - a directed-share allocation is not a decision. Where a 10% owner sold more than the cluster bought in the same week, the card says so.
Drug approvals and label expansions - the single cleanest binary catalyst feed for biotech and pharma names.
Names whose implied volatility jumped the most this week. When IV hits a 52-week high with earnings on the calendar, the straddle tells you the move the market is paying for.
Every US ETF with fees, AUM, returns and full risk analytics. Sorted by trailing 1-year return - but the drawdown column is where the leverage shows its teeth.
Mean-variance with James-Stein + Ledoit-Wolf shrinkage, solved under long-only, weight-capped constraints. The same risk engine behind every saved portfolio.
The engine flags its own bias: max-Sharpe fits the in-sample tangency portfolio and tends to overfit out-of-sample - min-variance and risk-parity are the more robust objectives. Shown here as the most legible demo.
Everything on this page is one query out of 202 tools. Connect Claude, ChatGPT or your own agent and ask the data anything - cross-surface, in plain language.